CSBR
Champions Oncology·NASDAQ
--
--(--)
--
--(--)
2.28 / 10
Underperform
Technically, CSBR is underperforming with a score of 2.28/10. Dominant bearish signals include the Hanging Man and Marubozu White patterns, both with low win rates and negative average returns. The MACD Golden Cross also shows a bearish bias, though the MACD Death Cross offers a mild bullish counterpoint. The preponderance of bearish indicators suggests caution and aligns with the Underperform rating.
Analysis Checks(1/4)
MACD Death Cross
Score6.13/10
Win Rate55.56%
Hist. Signals9
Avg Return2.11%
Score6.13/10
Win Rate55.56%
Hist. Signals9
Avg Return2.11%
Marubozu White
Score1/10
Win Rate39.29%
Hist. Signals28
Avg Return-2.15%
Score1/10
Win Rate39.29%
Hist. Signals28
Avg Return-2.15%
MACD Golden Cross
Score1/10
Win Rate20.00%
Hist. Signals10
Avg Return-4.44%
Score1/10
Win Rate20.00%
Hist. Signals10
Avg Return-4.44%
Hanging Man
Score1/10
Win Rate0.00%
Hist. Signals2
Avg Return-7.56%
Score1/10
Win Rate0.00%
Hist. Signals2
Avg Return-7.56%
MACD Death Cross
Score6.13/10
Win Rate55.56%
Hist. Signals9
Avg Return2.11%
Score6.13/10
Win Rate55.56%
Hist. Signals9
Avg Return2.11%
MACD Golden Cross
Score1/10
Win Rate20.00%
Hist. Signals10
Avg Return-4.44%
Score1/10
Win Rate20.00%
Hist. Signals10
Avg Return-4.44%
Marubozu White
Score1/10
Win Rate39.29%
Hist. Signals28
Avg Return-2.15%
Score1/10
Win Rate39.29%
Hist. Signals28
Avg Return-2.15%
Hanging Man
Score1/10
Win Rate0.00%
Hist. Signals2
Avg Return-7.56%
Score1/10
Win Rate0.00%
Hist. Signals2
Avg Return-7.56%
Technical Analysis of CSBR?
- CSBR presents a Underperform setup with a Technical Score of 2.28/10. Key technical indicators highlight an RSI of 41.55 and a MACD of -0.18, with the trend anchored by the 50-Day SMA at 6.79. Traders should monitor key support at 6.39 and resistance at 6.81.
